The FDA has cleared Precision BioSciences' plans to move a gene editing program into clinical trials. Precision BioSciences ...
After North Carolina's pension fund put up a 90% stake to acquire a 2-tower development in Downtown Raleigh, many real estate professionals have been wondering if similar deals are ahead.
RESEARCH TRIANGLE PARK, N.C., Feb. 17, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: BCRX) today announced that the company plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results